Trial Profile
A trial to investigate plasma protein binding and to evaluate target attainment rates of vancomycin therapy in critically ill children
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Vancomycin (Primary)
- Indications Gram-positive infections
- Focus Pharmacodynamics; Pharmacokinetics
- 18 May 2016 New trial record
- 12 Apr 2016 Results presented at the 26th European Congress of Clinical Microbiology and Infectious Diseases